A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2805-2809

  Olie, Robert A ^a   Simões Wüst, A Paula ^a   Baumann, Bettina ^b   Leech, Siân H ^a   Fabbro, Doriano ^c   Stahel, Rolf A ^a   Zangemeister Wittke, Uwe ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ETOPOSIDE; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHATIDYLETHANOLAMINES; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0342657718     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Vigna, N., Oltersdorf, T., and Reed, J. C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res., 58: 5315-5320, 1998.
2. Ambrosini, G., Adida, C., and Altieri, D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med., 3: 917-921, 1997.
3. Adida, C., Crotty, P. L., McGrath, J., Berrebi, D., Diebold, J., and Altieri, D. C. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol., 152: 43-49, 1998.
4. Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., and Altieri, D. C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature (Lond.), 396: 580-583, 1998.
5. Monzo, M., Rosell, R., Felip, E., Astudillo, J., Sanchez, J. J., Maestre, J., Martin, C., Font, A., Barnadas, A., and Abad, A. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognostic marker in non-small cell lung cancers. J. Clin. Oncol., 17: 2100-2104, 1999.
6. Jaattela, M. Escaping cell death: survival proteins in cancer. Exp. Cell Res., 248: 30-43, 1999.
7. Kawasaki, H., Altieri, D. C., Lu, C-D., Toyoda, M., Tenjo, T., and Tanigawa, N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res., 58: 5071-5074, 1999.
8. LaCasse, E. C., Baird, S., Komeluk, R. G., and MacKenzie, A. E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene, 17: 3247-3259, 1998.
9. Nakagawara, A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum. Cell, 11: 115-124, 1998.
10. Saitoh, Y., Yaginuma, Y., and Ishikawa, M. Analysis of bcl-2, bax and survivin genes in uterine cancer. Int. J. Oncol., 15: 137-141, 1999.
11. Ambrosini, G., Adida, C., Sirugo, G., and Altieri, D. C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem., 273: 11177-11182, 1998.
12. Grossman, D., McNiff, J. M., Li, F., and Altieri, D. C. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab. Invest., 79: 1121-1126, 1999.
13. Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., and Altieri, D. C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol., 1: 461-456, 1999.
14. Matzura, O., and Wennborg, A. RNAdraw: an integrated program for RNA secondary structure calculation and analysis under 32-bit Microsoft Windows. Comput. Appl. Biosci., 12: 247-249, 1996.
15. Zangemeister-Wittke, U., and Ziegler, A. Bcl-2 antisense therapy for cancer: the art of persuading tumour cells to commit suicide. Apoptosis, 3: 67-74, 1998.
16. Ziegler A., Simões-Wüst, A. P., and Zangemeister-Wittke, U. Optimizing the efficacy of antisense oligodeoxynucleotides targeting inhibitors of apoptosis. In: M. I. Philips (ed.), Antisense Technology, Part B, Vol. 314, pp. 477-490, Methods Enzymology. San Diego, CA: Academic Press, 1999.
17. Gibson, U. E., Heid, C. A., and Williams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996.
18. Heid, C. A., Stevens, J., Likak, K. J., and Williams, P. M. Real time quantitative PCR. Genome Res., 6: 986-994, 1996.
19. Oh, J. H., Omalley, K. L., Krajewski, S., Reed, J. C., and Oh, Y. J. Bax accelerates staurosporine-induced but suppresses nigericin-induced neuronal cell death. Neuroreport, 8: 1851-1856, 1997.
20. Ziegler, A., Luedke, G. H., Fabbro, D., Altmann, K. H., and Zangemeister-Wittke, U. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J. Natl. Cancer Inst., 89: 1027-1036, 1997.
21. Zangemeister-Wittke, U., Schenker, T., Luedke, G. H., and Stahel, R. A. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small cell lung cancer cell lines. Br. J. Cancer, 78: 1035-1042, 1998.
22. Olie, R. A., Durrieu, F., Cornillon, S., Loughran, G., Gross, J., Earnshaw, W. C., and Golstein, P. Apparent caspase independence of programmed cell death in Dictyostelium. Curr. Biol., 8: 955-958, 1998.
23. Leech, S. H., Olie, R. A., Simões-Wüst, A. P., Tschopp, S., Häner, R., Hall, J., Stahel, R. A., and Zangemeister-Wittke, U. Induction of apoptosis in lung cancer cells following bcl-xL antisense treatment. Int. J. Cancer, in press, 2000.
24. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T-I., Jones, D. P., and Wang, X. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science (Washington DC), 275: 1129-1132, 1997.